Peker, I.; İçli, H.E.; Mutluay, B.; Yüksel, B.; Özdemir, Z.; Köseoğlu, M.; Şen, A.; Ataklı, D.; Soysal, A.; Öztürk, M.
Prognostic Value of CXCL13, CCL11, and CCL20 Chemokines in Multiple Sclerosis. Biomedicines 2025, 13, 40.
https://doi.org/10.3390/biomedicines13010040
AMA Style
Peker I, İçli HE, Mutluay B, Yüksel B, Özdemir Z, Köseoğlu M, Şen A, Ataklı D, Soysal A, Öztürk M.
Prognostic Value of CXCL13, CCL11, and CCL20 Chemokines in Multiple Sclerosis. Biomedicines. 2025; 13(1):40.
https://doi.org/10.3390/biomedicines13010040
Chicago/Turabian Style
Peker, Işıl, Hacer Eroğlu İçli, Belgin Mutluay, Burcu Yüksel, Zeynep Özdemir, Mesrure Köseoğlu, Aysu Şen, Dilek Ataklı, Aysun Soysal, and Musa Öztürk.
2025. "Prognostic Value of CXCL13, CCL11, and CCL20 Chemokines in Multiple Sclerosis" Biomedicines 13, no. 1: 40.
https://doi.org/10.3390/biomedicines13010040
APA Style
Peker, I., İçli, H. E., Mutluay, B., Yüksel, B., Özdemir, Z., Köseoğlu, M., Şen, A., Ataklı, D., Soysal, A., & Öztürk, M.
(2025). Prognostic Value of CXCL13, CCL11, and CCL20 Chemokines in Multiple Sclerosis. Biomedicines, 13(1), 40.
https://doi.org/10.3390/biomedicines13010040
